Management of Tricuspid Regurgitation—What’s Next?

This Viewpoint discusses the need to better define whom to treat, when to intervene, how and why to perform an intervention, and what benefit to expect in the management of tricuspid regurgitation.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2025-05-08
DOI
https://doi.org/10.1001/jama.2025.5391
Citations
8
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
11.11
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management of Tricuspid Regurgitation—What’s Next?

Julien Dreyfus, David Messika‐Zeitoun
8 citations
JAMA
Cardiac Valve Diseases and Treatments
11.11
article

Management of Tricuspid Regurgitation—What’s Next?

Julien Dreyfus, David Messika‐Zeitoun
article en
8 citations

Abstract

This Viewpoint discusses the need to better define whom to treat, when to intervene, how and why to perform an intervention, and what benefit to expect in the management of tricuspid regurgitation.

JAMAVol. 333(23)
University of Ottawa (CA), Centre Cardiologique du Nord (FR)
Openalex Percentile: Top 1%
Cardiac Valve Diseases and Treatments
11.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Management of Tricuspid Regurgitation—What’s Next? — Julien Dreyfus, David Messika‐Zeitoun · JAMA (2025) | TGRS Research Map | TGRS